15.11.2012 Views

BioBasic SCX and AX Columns - Chromatopak.com

BioBasic SCX and AX Columns - Chromatopak.com

BioBasic SCX and AX Columns - Chromatopak.com

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>BioBasic</strong> ® <strong>SCX</strong> <strong>and</strong> <strong>AX</strong><br />

<strong>Columns</strong><br />

TG02-01<br />

Silica-based ion exchange columns for<br />

cation <strong>and</strong> anion exchange chromatography


2<br />

Technical Guide<br />

<strong>BioBasic</strong> ® <strong>SCX</strong> <strong>and</strong> <strong>AX</strong> <strong>Columns</strong>s<br />

Using <strong>BioBasic</strong> ® <strong>SCX</strong> <strong>and</strong> <strong>AX</strong> for<br />

Ion Exchange Chromatography<br />

<strong>BioBasic</strong> ion exchange columns are the first in a new generation of HPLC columns that make use of polymeric ion<br />

exchange lig<strong>and</strong> technology bound to a high quality base deactivated silica. This unique <strong>com</strong>bination gives rise to a<br />

highly efficient <strong>and</strong> stable polymeric coating that is very robust <strong>and</strong> reproducible. The columns can be used in any one<br />

of several modes of operation: ion exchange, normal phase, <strong>and</strong> hydrophilic interaction chromatography.<br />

BioB BioB BioBaaaaasssssic BioB BioB ic ic ic ic <strong>AX</strong> <strong>AX</strong> <strong>AX</strong> <strong>AX</strong> <strong>AX</strong> fffor<br />

ffor<br />

or or or Anion Anion Anion Anion Anion Ex Ex Exccccchhhhhan Ex Ex an an anggggge an e e e e Chr Chr Chrom Chr Chrom<br />

om omat omat<br />

at atogr atogr<br />

ogr ograph ographyyyyy.<br />

aph aph aph Anion exchange chromatography is an electrostatic interaction<br />

between a negatively charged analyte <strong>and</strong> a positively charged stationary phase. Retained analytes are eluted<br />

by the introduction of a salt that <strong>com</strong>petes with the analyte for the ion exchange site.<br />

BioB BioB BioBaaaaasssssic BioB BioB ic ic ic ic <strong>SCX</strong> <strong>SCX</strong> <strong>SCX</strong> <strong>SCX</strong> <strong>SCX</strong> fffor<br />

ffor<br />

or or or CC<br />

Cation CC<br />

ation ation ation ation Ex Ex Exccccchhhhhan Ex Ex an an anggggge an e e e e Chr Chr Chrom Chr Chrom<br />

om omat omat<br />

at atogr atogr<br />

ogr ograph ograph<br />

aph aphyyyyy..... aph Cation exchange chromatography is an electrostatic interaction<br />

between a positively charged analyte <strong>and</strong> a negatively charged stationary phase. Retained analytes are<br />

eluted by the introduction of a salt that <strong>com</strong>petes with the analyte for the ion exchange site.<br />

BioB BioB BioBaaaaasssssic BioB BioB ic ic ic ic <strong>AX</strong> <strong>AX</strong> <strong>AX</strong> <strong>AX</strong> <strong>AX</strong> fffor<br />

ffor<br />

or or or Norm Norm Normal Norm Normal<br />

al al al Ph Ph Phaaaaase Ph Ph se se se se Chr Chr Chrom Chr Chrom<br />

om omat omat<br />

at atogr atogr<br />

ogr ograph ograph<br />

aph aphyyyyy. aph Normal phase chromatography is governed by the ability of the<br />

analyte to hydrogen bond with the stationary phase. Retention is controlled by adding small quantities of a<br />

<strong>com</strong>peting solvent with hydrogen bonding properties to the mobile phase (e.g. ethyl acetate).<br />

BioB BioB BioBaaaaasssssic BioB BioB ic ic ic ic <strong>AX</strong> <strong>AX</strong> <strong>AX</strong> <strong>AX</strong> <strong>AX</strong> fffor<br />

ffor<br />

or or or Hy Hy Hydr Hy Hydr<br />

dr drophi drophi<br />

ophi ophilic ophilic<br />

lic lic lic Int Int Inter Int Inter<br />

er eraction eraction<br />

action action action Chr Chr Chrom Chr Chrom<br />

om omat omat<br />

at atogr atogr<br />

ogr ograph ograph<br />

aph aphyyyyy aph (HILIC). (HILIC). (HILIC). (HILIC). (HILIC). HILIC is similar to normal phase chromatography.<br />

In this mode however, portions of the mobile phase are aqueous. In the HILIC mode, retention increases<br />

with the polarity of the analyte <strong>and</strong> retention decreases with the polarity of the eluent. The stationary phase<br />

easily adsorbs water from the mobile phase making it very hydrophilic.<br />

� Si Silic Si lic lica-b lica-b<br />

a-b a-based a-b sed ion ion ee<br />

exchan e an ange an<br />

column lumn lumns lumn fffor<br />

ff<br />

or c ccation<br />

c ation <strong>and</strong> <strong>and</strong> anion<br />

anion<br />

exchan an an ange an e c cchr<br />

c hr hrom hr om omat om at atogr at ogr ograph ogr aph aphy aph<br />

� 300Å 300Å 300Å por por pore por por e s ssiz<br />

s siz<br />

iz ize ize<br />

e fffor<br />

ff<br />

or pr prot pr prot<br />

ot otein ot ein<br />

sep separ sep ar aration ar ation ations ation<br />

� Low w c ccap<br />

c ap apac ap ac acity acity<br />

ity c ccolumn<br />

c lumn lumns lumn f ffor<br />

ff<br />

or lo low lo<br />

ionic ionic s sstr<br />

s tr tren tr en ength en th elution<br />

elution<br />

� Superior uperior uperior c ccolumn<br />

c lumn lif lifetime lif etime etimes etime <strong>and</strong> <strong>and</strong><br />

<strong>and</strong><br />

effic efficienc effic ienc iencie ienc ie ies ie<br />

Ap Ap Apppppplic Ap Ap lic lic lication lication<br />

ation ationsssss ation<br />

� Nuc Nucleotide<br />

Nuc eotide eotides eotide<br />

� Pr Prot Pr ot otein ot ein eins ein <strong>and</strong> <strong>and</strong> <strong>and</strong> peptide peptides peptide<br />

� Ar Arom Ar om omatic om atic ac acid ac id ids id<br />

� Sug ug ugar ug ar ars ar<br />

� Pho Phospho Pho pho pholipid pho lipid lipids lipid<br />

� Antib Antibiotic Antib iotic iotics<br />

iotic<br />

Figure 1a shows the separation of 12 nucleotides using <strong>BioBasic</strong> <strong>AX</strong> in<br />

the ion exchange mode.<br />

Figure 1b shows the separation of 5 proteins using the <strong>BioBasic</strong> <strong>SCX</strong><br />

column in ion exchange mode.<br />

figure 1a. Nucleotides<br />

2<br />

1 3<br />

Sample: 1. CMP<br />

2. UMP<br />

3. AMP<br />

4. GMP<br />

5. CDP<br />

6. ADP<br />

4<br />

5<br />

6<br />

7<br />

8<br />

7. UDP<br />

8. GDP<br />

9. CTP<br />

10. ATP<br />

11. UTP<br />

12. GTP<br />

9 10 11 12<br />

731-001<br />

0 5 10 15 20 25 30 35 MIN<br />

<strong>BioBasic</strong> <strong>AX</strong>, 5µm, 150x4.6mm<br />

Gradient: A: 5mM KH PO , pH 3.2<br />

2 4<br />

B: 0.75M KH PO , pH 3.2<br />

2 4<br />

0-100% B in 30 min<br />

Flow: 1.0 mL/min<br />

Detector: UV @ 254<br />

figure 1b. Proteins with Tris Buffer<br />

Sample:<br />

1. Trypsinogen<br />

2. Ribonuclease A<br />

3. Chymotrypsinogen A<br />

4. Cytochrome C<br />

5. Lysozyme<br />

1<br />

<strong>BioBasic</strong> <strong>SCX</strong>, 5µm, 150x4.6mm<br />

Gradient: A: 0.02M Tris, pH 6<br />

B: A + 1.0M Na Acetate, pH 6<br />

0-100% B in 60 min<br />

Flow: 1.0 mL/min<br />

Detector: UV @ 280<br />

2<br />

3<br />

4<br />

5<br />

732-002<br />

0 5 10 15 20 25 30 35 MIN


<strong>BioBasic</strong> <strong>AX</strong> Polyethyleneimine Structure <strong>and</strong> Ion Exchange Capacity<br />

1. <strong>BioBasic</strong> <strong>AX</strong> is an anion exchange packing consisting of polyethyleneimine (PEI) covalently bound to a highly<br />

base deactivated 300Å, 5µm silica. Polyethyleneimine has a polymeric structure (Figure 2).<br />

Particle size 5µm<br />

Pore size 300Å<br />

Ion exchange lig<strong>and</strong> PEI<br />

Ion exchange capacity 0.22mequivalents/gram<br />

Surface chemistry schematic see Figure 2<br />

Figure 2. Structure of PEI<br />

Branching during polymerization leads to 30% primary, 40% secondary, <strong>and</strong> 30% tertiary amines.<br />

The ion exchange capacity of <strong>BioBasic</strong> <strong>AX</strong> is measured by titration. Details concerning the method <strong>and</strong> calculation<br />

are presented in Figure 3b.<br />

The measured capacity is 0.22 mequivalents/gram. This measured capacity <strong>com</strong>pares to other low capacity<br />

ion exchangers available. The low capacity allows the use of moderate to low buffer concentrations when<br />

eluting samples from the column – a real benefit where mass spectrometry(MS) is the mode of detection.<br />

<strong>BioBasic</strong> <strong>AX</strong> was primarily developed as a high performance ion exchange packing, but it has also been<br />

successfully used for HILIC <strong>and</strong> Normal Phase Chromatography (NPC). The ion exchange mode <strong>and</strong> HILIC<br />

modes are discussed more <strong>com</strong>pletely in the following paragraphs.<br />

<strong>BioBasic</strong> <strong>SCX</strong> Structure <strong>and</strong> Ion Exchange Capacity<br />

2. <strong>BioBasic</strong> <strong>SCX</strong> packing is a strong cation exchange packing consisting of highly base deactivated 300Å, 5µm<br />

silica with a sulphonic acid derivatized hydrophilic polymer coating that provides excellent stability <strong>and</strong> an<br />

excellent surface for protein chromatography i.e. relatively minor secondary interactions (Figure 3a).<br />

Particle size 5µm<br />

Pore size 300Å<br />

Ion exchange lig<strong>and</strong> Sulphonic acid<br />

Ion exchange capacity 0.07 mequivalents/gram<br />

Surface chemistry schematic see Figure 3a<br />

Figure 3a. Sulfonic Acid Structure<br />

The ion exchange capacity of <strong>BioBasic</strong> <strong>SCX</strong> is measured by titration. Details concerning the method <strong>and</strong><br />

calculation are presented in Figure 3b.<br />

The measured capacity is 0.07 mequivalents/gram. This capacity is actually slightly less than other low<br />

capacity ion exchangers available. While this lower capacity means that sample concentration may need to be<br />

reduced so as not to overload the column, it does allow for the use of lower buffer concentrations for elution<br />

than typically expected. This characteristic is quite beneficial for the MS mode of detection.<br />

<strong>BioBasic</strong> <strong>SCX</strong> was primarily developed as a high performance ion exchange packing for traditional analytical<br />

separations, but it has also been shown to be particularly proficient at fractionation of <strong>com</strong>plex mixtures of<br />

proteins.<br />

3


4<br />

Technical Guide<br />

<strong>BioBasic</strong> ® <strong>SCX</strong> <strong>and</strong> <strong>AX</strong> <strong>Columns</strong><br />

Figure 3b. <strong>BioBasic</strong> ® <strong>AX</strong> Ion Exchange Capacity Determination by Titration<br />

Basic Principles of Ion Exchange Chromatography<br />

Purpose: To determine the fundamental<br />

ion exchange capacity <strong>and</strong><br />

demonstrate the effective weak<br />

anion exchange pH range for<br />

Biobasic <strong>AX</strong>.<br />

Reference: A.J. Alpert <strong>and</strong> F. E. Regnier J.<br />

Chrom 185 (1979)<br />

pgs 375-392<br />

Method: 0.600g of lot R0J17 was sus<br />

pended in 20mL of 0.5M<br />

sodium chloride. The stirred<br />

suspension was then titrated<br />

using 0.0408N HCL. The pH<br />

was monitored using a pH meter<br />

<strong>and</strong> probe rather than a visual<br />

indicator.<br />

Most ion exchange packings fall into two groups: those which contain acid groups, such as sulphonic acid or carboxylic<br />

acid, for the separation of cationic <strong>com</strong>pounds, <strong>and</strong> those which contain a basic group, such as an amine or quaternary<br />

amine, for the separation of anionic <strong>com</strong>pounds. It is important to buffer the mobile phase in this mode of chromatography<br />

to control the ionization of both the analyte <strong>and</strong> the packing, since the ionic state of both affects the acid-base<br />

equilibria between analyte <strong>and</strong> ion exchange packing. A strong anion exchange media such as <strong>BioBasic</strong> <strong>AX</strong> will be ionized<br />

over most of the pH range 2-8. A weak anion exchange media can be turned “on” <strong>and</strong> “off” within that range through<br />

changes in the pH of the mobile phase. It is important to emphasize that, while the ion exchange capacity of <strong>BioBasic</strong> <strong>AX</strong><br />

will be maximized at low pH, it will still have some ionic character <strong>and</strong> function as an ion exchanger even at pH 8. This<br />

makes <strong>BioBasic</strong> <strong>AX</strong> very versatile <strong>and</strong> makes pH a powerful tool for modifying selectivity.<br />

The anion exchange process may be represented by the equilibrium [1],<br />

which would apply for an anion exchange material such as <strong>BioBasic</strong> <strong>AX</strong> :<br />

where C- is the counter ion to the fixed ion exchange site, ~NH + , present in the eluent. Analyte X- can then displace C- to<br />

give the ion pair NH + X- . For effective chromatography, this displacement reaction must be at equilibrium. Retention is<br />

therefore controlled by the equilibrium [1] for which the equilibrium constant KIE is given by equation [2]:<br />

The capacity factor, k, of an analyte (X - ) is a more useful chromatographic paramater <strong>and</strong> is proportional to the distribution<br />

coefficient, D IE . Its relationship equilibrium constant, K IE , is given by equation [3]:<br />

Since the concentration of the ion exchange sites, [~NH + X - ], is constant <strong>and</strong> fixed by the rigid structure of the matrix, k is<br />

inversely proportional to the concentration of the counter ion (ionic strength) in the eluent:<br />

Desorption is then brought about by increasing the salt concentration as shown by equation [4].<br />

[1]<br />

[2]<br />

[3]<br />

[4]


Ion Exchange Chromatographic<br />

Characteristics of <strong>BioBasic</strong> <strong>AX</strong> <strong>and</strong><br />

<strong>BioBasic</strong> <strong>SCX</strong><br />

In ion exchange chromatography,<br />

conditions are employed that permit<br />

the sample <strong>com</strong>ponents to move<br />

through the column at different<br />

speeds. The higher the net charge of<br />

the analyte, the higher the ionic<br />

strength needed to bring about<br />

desorption. At a certain high level of<br />

ionic strength, all the sample<br />

<strong>com</strong>ponents are fully desorbed <strong>and</strong><br />

move down the column with the<br />

same speed as the mobile phase.<br />

Conditions that lie somewhere in<br />

between total adsorption <strong>and</strong> total<br />

desorption will provide the optimal<br />

selectivity for a given pH value of the<br />

mobile phase. The effect of ionic<br />

strength on analyte retention is clearly<br />

shown in Figures 4a <strong>and</strong> 4b. The term<br />

adsorption used here in a general<br />

sense refers to the attraction of an<br />

analyte ion for the ionic sites of the<br />

packing. It should not be confused<br />

with the same term used for<br />

adsorption chromatography where<br />

traditional hydrogen bonding is the<br />

mechanism by which analytes are<br />

retained at the surface.<br />

The <strong>com</strong>petition between analyte <strong>and</strong><br />

salt for the ion exchange site is largely<br />

controlled by the concentration <strong>and</strong><br />

nature of the salt ion. Choice of the<br />

appropriate counter ion is therefore of<br />

significant importance in adjusting<br />

retention. One usually employs H + ,<br />

Na + , K +, , Ca2+ - for cation <strong>and</strong> NO , 3<br />

2- 3- SO , PO4 , etc. for anion exchangers.<br />

4<br />

For example, by substituting the<br />

eluent ion of a cation exchanger in the<br />

series H + , Na + , K + ,Ca2+ the relative<br />

strength between counter ion <strong>and</strong><br />

fixed ion increases <strong>and</strong> retention of a<br />

given cation (analyte) decreases.<br />

The concentration, or alternatively<br />

ionic strength, of the counter ion also<br />

plays an important role in controlling<br />

retention. At low ionic strengths, all<br />

<strong>com</strong>ponents with affinity for the ion<br />

exchanger are strongly adsorbed at<br />

the top of the ion exchange column<br />

<strong>and</strong> elution is slow. As the ionic<br />

strength of the mobile phase is<br />

increased by increasing the concentration<br />

of a salt, salt ions <strong>com</strong>pete<br />

more strongly with the analyte for the<br />

ion exchange site. The sample starts<br />

moving down the column more<br />

quickly, causing the elution time to be<br />

reduced. Increasing the ionic strength<br />

even more causes a further reduction<br />

in elution time until the analyte does<br />

not spend any time in the stationary<br />

phase.<br />

Figure 4a. Effect of Buffer Concentration<br />

4<br />

1<br />

3<br />

2<br />

5 8<br />

7<br />

6<br />

4<br />

1<br />

3<br />

2<br />

5<br />

7<br />

6<br />

1<br />

1<br />

2<br />

3<br />

4 5<br />

2 3<br />

6<br />

4 5<br />

7<br />

6<br />

8<br />

<strong>BioBasic</strong> <strong>AX</strong><br />

90mM<br />

70mM<br />

8<br />

7<br />

Sample:<br />

1. Uracil<br />

2. Shikimic Acid<br />

3. Ascorbic Acid<br />

4. Phenylacetic Acid<br />

5. Sorbic Aci<br />

6. Benzoic Acid<br />

7. Vanillic Acid<br />

8. p-Coumeric Acid<br />

50mM<br />

731-008<br />

0 4 8 12 MIN<br />

8<br />

30mM<br />

<strong>BioBasic</strong> ® <strong>AX</strong>, 5µm, 50x4.6mm<br />

Eluent: A: NH 4 Acetate, pH 5.7<br />

B: Acetonitrile<br />

95%A / 5%B<br />

Flow: 1.0 mL/min<br />

Detector: UV @ 225<br />

Sample <strong>com</strong>ponents can vary<br />

considerably in their adsorption to the<br />

ion exchange sites so that a single<br />

value of the ionic strength cannot<br />

make all analytes (both strongly <strong>and</strong><br />

weakly retained) pass through the<br />

column in a reasonable time. In such<br />

cases, a salt gradient is applied. This<br />

causes a gradual increase in ionic<br />

strength in the mobile phase. This<br />

gradient gradually desorbs the sample<br />

<strong>com</strong>ponents in the order of increasing<br />

net charge, so that <strong>com</strong>ponents are<br />

picked off one at a time from the<br />

surface to provide separation of the<br />

mixture. Thus the salt gradient<br />

<strong>com</strong>presses a chromatogram so as to<br />

elute <strong>com</strong>ponents with widely<br />

different adsorptive properties within a<br />

reasonable time.<br />

Figure 4b. Effect of Buffer Concentration<br />

1<br />

1<br />

1<br />

2<br />

2<br />

2<br />

3<br />

4<br />

5 6<br />

3<br />

5 6<br />

4<br />

3<br />

<strong>BioBasic</strong> <strong>SCX</strong><br />

30mM<br />

20mM<br />

Sample:<br />

1. Caffeine<br />

2. Pyridine<br />

3. Diphenhydramine<br />

4. Dextromethorphan<br />

5. Pseudoephedrine<br />

6. Nicotine<br />

5 6<br />

4<br />

10mM<br />

732-003<br />

0 2 4 6 MIN<br />

<strong>BioBasic</strong> <strong>SCX</strong>, 5µm, 150x4.6mm<br />

Eluent: 60% NH 4 Acetate, pH 4.5 / 40% ACN<br />

Flow: 1.0 mL/min<br />

Detector: UV @ 254<br />

5


6<br />

Technical Guide<br />

<strong>BioBasic</strong> ® <strong>SCX</strong> <strong>and</strong> <strong>AX</strong> <strong>Columns</strong><br />

pH Control<br />

pH can have considerable effect on<br />

retention <strong>and</strong> selectivity. This is because:<br />

1. a shift in pH that causes the<br />

analyte to change from its<br />

ionized state to its neutral<br />

state prevents the analyte<br />

from taking part in the ion exchange<br />

process <strong>and</strong> consequently<br />

retention is reduced.<br />

2. a shift in pH that causes the ion<br />

exchange site to change from<br />

its ionized state to a neutral<br />

state essentially eliminates<br />

sites available for ion exchange<br />

<strong>and</strong> retention is lost.<br />

Maximizing Column Efficiency <strong>and</strong><br />

Resolution<br />

High column efficiency (number of theoretical<br />

plates) is an important factor to<br />

consider when trying to maximize the<br />

potential resolution in a given separation.<br />

In ion exchange chromatography<br />

the sharpness of a peak is governed<br />

not only by how well the column is<br />

packed but also by the mass transfer<br />

characteristics of the ion exchange<br />

mechanism itself. The term mass transfer<br />

used here refers to the efficient migration<br />

of the analyte from the mobile<br />

phase on to the stationary phase ion<br />

exchange site <strong>and</strong> then back into the<br />

the mobile phase from the ion exchange<br />

site. If this process is not very rapid,<br />

broad peaks can result with a possible<br />

loss in analyte resolution. Figure 5a illustrates<br />

how the column efficiency increases<br />

as the flow rate is reduced for<br />

a 150 x 4.6mm column. Depending on<br />

the <strong>com</strong>plexity of the analysis, a tradeoff<br />

is required between time <strong>and</strong> efficiency.<br />

Even at moderate flow rates,<br />

the column efficiency is still very impressive<br />

for ion exchange.<br />

The mass transfer <strong>com</strong>ponent of the<br />

Van Deemter equation can often be improved<br />

through temperature control.<br />

The mass transfer can be increased by<br />

increasing the temperature at which the<br />

separation takes place. The way in which<br />

column temperature is achieved is also<br />

of significant importance. Figure 5b<br />

shows the effect that increasing column<br />

temperature has on efficiency. It is important<br />

to note the role of preheating<br />

the mobile phase on the separation.<br />

For example, heating only the column<br />

itself <strong>and</strong> not heating the solvent supplied<br />

to it can actually increase b<strong>and</strong><br />

spreading <strong>and</strong> reduce column efficiency<br />

as shown in Figure 5b. Heating the solvent<br />

prior to its arrival at the column<br />

prevents this b<strong>and</strong> spreading <strong>and</strong> improves<br />

the mass transfer associated<br />

with the ion exchange mechanism. The<br />

result is an increase in the column efficiency<br />

for any given flow rate. For further<br />

information on temperature control<br />

please contact Thermo Hypersil-<br />

Keystone <strong>and</strong> request the Hot Pocket<br />

Product Bulletin.<br />

Figure 5a. The Effect of Flow Rate<br />

on Efficiency in Ion Exchange Mode<br />

Figure 5b. The Effect of Temperature<br />

on Efficiency in Ion Exchange Mode<br />

Attributes of <strong>BioBasic</strong> Ion Exchange Packings<br />

<strong>BioBasic</strong> <strong>AX</strong> <strong>and</strong> <strong>SCX</strong> are the first in a new generation of high performance<br />

ion exchange columns for HPLC. They offer:<br />

1. Proven batch-to-batch reproducibility<br />

2. High efficiency, measured at >80,000 plates/meter<br />

3. Excellent phase stability<br />

4. Suitability for the separation of small highly polar pharmaceutical<br />

<strong>com</strong>pounds <strong>and</strong> also larger biochemical molecules such as proteins<br />

<strong>and</strong> peptides<br />

5. A broad application range<br />

6. <strong>BioBasic</strong> <strong>AX</strong> offers - three modes of retention: a) anion exchange,<br />

b) normal phase <strong>and</strong> c) hydrophilic interaction chromatography<br />

7. <strong>BioBasic</strong> <strong>SCX</strong> has proven to be highly proficient at protein digest<br />

fractionation <strong>and</strong> is consequently ideal for applications in the field<br />

of proteomics.


Lot to Lot <strong>and</strong> Column to Column<br />

Reproducibility<br />

Each lot of <strong>BioBasic</strong> <strong>AX</strong> <strong>and</strong> <strong>BioBasic</strong><br />

<strong>SCX</strong> is bonded to very tight specifications.<br />

Lots are tested chromatographically<br />

(Figure 6a <strong>and</strong> 6b) with ionic<br />

probes using buffered mobile phase<br />

conditions in order to fully characterize<br />

the ionic interactions that take place at<br />

the packing surface.<br />

Individual columns packed from any<br />

given lot are also tested chromatographically<br />

in order to ensure the high<br />

performance that might be expected<br />

from the spherical 5µm base deactivated<br />

silica particles that are used as<br />

the base to both the <strong>BioBasic</strong> <strong>AX</strong> <strong>and</strong><br />

<strong>SCX</strong> polymeric bonded phases (Figure<br />

7). Typical efficiencies are greater than<br />

80,000 plates per meter when tested<br />

in the normal phase mode.<br />

Phase Stability<br />

The unique way in which the<br />

hydrophilic polymer is bonded to the<br />

highly base deactivated silica<br />

provides a very stable surface on<br />

which chromatography takes place.<br />

<strong>BioBasic</strong> <strong>SCX</strong> Stability<br />

Stability trials have been carried out<br />

at pH 2.5 <strong>and</strong> pH 6 on <strong>BioBasic</strong> <strong>SCX</strong>.<br />

The trials involved testing two<br />

separate columns, each subjected<br />

to:<br />

a. >14,000 column volumes of<br />

0.05M KH PO at pH 2.5,<br />

2 4<br />

adjusted with H PO 3 4<br />

b. >15,000 column volumes of<br />

0.05M KH PO at pH 6,<br />

2 4<br />

adjusted with KOH<br />

The columns were removed at<br />

regular intervals <strong>and</strong> tested chromatographically<br />

using the test<br />

procedure outlined in Figure 8. The<br />

retention of Nicotine was then<br />

recorded <strong>and</strong> plotted as shown in<br />

Figure 8.<br />

figure 6a. <strong>BioBasic</strong> ® <strong>AX</strong><br />

Batch-to-Batch Reproducibility figure 6b. Peptides<br />

1<br />

Sample:<br />

1. Uracil<br />

2. UMP<br />

3. AMP<br />

4. GMP<br />

2<br />

731-009<br />

0 2 4 6 8 MIN<br />

<strong>BioBasic</strong> <strong>AX</strong>, 5µm, 150x4.6mm<br />

Eluent: 0.05M KH 2 PO 4 , pH 4.68<br />

Flow: 1.0 mL/min<br />

Detector: UV @ 254<br />

3<br />

4<br />

POK10<br />

ROJ18<br />

POK11<br />

figure 7. Normal Phase Efficiency<br />

1<br />

2<br />

3<br />

4<br />

<strong>BioBasic</strong> <strong>AX</strong><br />

N = 81,628<br />

Sample:<br />

1. Toluene<br />

2. Nitrobenzene<br />

3. o-Nitroaniline<br />

4. m-Nitroaniline<br />

5. p-Nitroaniline<br />

0 2 4 6 MIN<br />

<strong>Columns</strong>: 5µm, 150x4.6mm<br />

Eluent: 85% IsoOctane / 15% EtOH (0.3% HOH)<br />

Flow: 1.25 mL/min<br />

Detector: UV @ 254<br />

5<br />

731-011<br />

<strong>BioBasic</strong> <strong>AX</strong> Stability<br />

Stability trials have been carried out at<br />

pH 2.5 <strong>and</strong> pH 8 on <strong>BioBasic</strong> <strong>AX</strong>. The<br />

trials involved testing two separate columns,<br />

each subjected to:<br />

Sample:<br />

1. Ac-G-G-G-L-G-G-A-G-G-L-K-amide<br />

2. Ac-K-Y-G-L-G-G-A-G-G-L-K-amide<br />

3. Ac-G-G-A-L-K-A-L-K-G-L-K-amide<br />

4. Ac-K-Y-A-L-K-A-L-K-G-L-K-amide<br />

002-145<br />

0109010A<br />

732-006<br />

0 2 4 6 8 10 12 MIN<br />

<strong>BioBasic</strong> <strong>SCX</strong>, 5µm, 50x4.6mm<br />

Eluent: A: 10mM KH 2 PO 4 in 25% ACN<br />

(pH adjusted to 4.8 with H 3 PO 4 )<br />

B: A + 0.5M NaCl<br />

0->50% B in 20 min<br />

Flow: 1.0 mL/min<br />

Detector: UV @ 210<br />

<strong>BioBasic</strong> <strong>SCX</strong><br />

N = 82,305<br />

1<br />

0 1 2 3 MIN<br />

2<br />

3<br />

002-148<br />

732-001<br />

a. a. >15,000 column volumes of 0.05M<br />

KH PO at pH 2.5, adjusted with<br />

2 4<br />

H PO 3 4<br />

b. >15,000 column volumes of 0.05M<br />

KH PO at pH 8, adjusted with KOH<br />

2 4<br />

7


8<br />

Technical Guide<br />

<strong>BioBasic</strong> ® <strong>SCX</strong> <strong>and</strong> <strong>AX</strong> <strong>Columns</strong><br />

The columns were removed at regular<br />

intervals <strong>and</strong> tested chromatographically<br />

using the test procedure outlined<br />

between Figures 9a <strong>and</strong> 9b. The<br />

retention of GMP was then recorded<br />

<strong>and</strong> plotted in these Figures.<br />

pH 2.5 Conditions<br />

Eluent: 60% 10mM NH 4 Acetate,<br />

pH 4.5 / 40% ACN<br />

Flow: 1.0 mL/min<br />

Detector: UV @ 254<br />

Figures 9a & 9b. Stability of <strong>BioBasic</strong><br />

Column retention restored<br />

® <strong>AX</strong> at pH 2.5 <strong>and</strong> at pH 8<br />

pH pH 2.5<br />

2.5<br />

pH pH 8<br />

8<br />

<strong>BioBasic</strong> <strong>SCX</strong>, 50x4.6mm<br />

The results show that at both pH 2.5<br />

<strong>and</strong> pH 8 some loss in column<br />

retention does occur. This is largely<br />

due to the adsorption of impurities<br />

from the phosphate buffer itself.<br />

These are easily removed by using a<br />

Figure 8. <strong>BioBasic</strong> <strong>SCX</strong> Column Stability @ pH 2.5 <strong>and</strong> pH 6.0<br />

pH 6 Conditions<br />

Eluent: 70% 10mM NH4 Formate,<br />

pH 3.1 / 30% ACN<br />

Flow: 1.0 mL/min<br />

Detector: UV @ 260<br />

pH 8 <strong>and</strong> pH 2.5 Conditions<br />

<strong>BioBasic</strong> <strong>AX</strong>, 5µm, 150x4.6mm<br />

Eluent: 5mM KH PO , pH 6.5<br />

2 4<br />

Flow: 1.0 mL/min<br />

Detector: UV @ 254<br />

Column retention restored<br />

high concentration salt gradient<br />

regeneration program. Once this has<br />

been done, capacity factors are<br />

restored to within 5% of their original<br />

values. This observation was made for<br />

both pH trials, as shown by the circled<br />

areas in Figures 9a <strong>and</strong> 9b. The<br />

regeneration procedure used is given<br />

in Figure 10.<br />

Figure 10. Regeneration of<br />

Retention with Salt Gradients<br />

Regeneration<br />

Procedure:<br />

Conditions: A: 0.1M KH 2 PO 4 , pH not adjusted<br />

B: 0.7M KH 2 PO 4 , pH not adjusted<br />

Gradient: 0-100% B in 15 min.<br />

- Run several gradients to clean column <strong>and</strong><br />

free ion exchange sites.<br />

1<br />

1<br />

1<br />

2<br />

2<br />

2<br />

3<br />

3<br />

Sample:<br />

1. Uracil<br />

2. UMP<br />

3. CMP<br />

3<br />

After 15,000 Column<br />

Volumes @<br />

pH 2.5 0.05M KH 2 PO 4<br />

4<br />

New Column<br />

4 5<br />

4<br />

5<br />

Regeneration After 3<br />

Strong Salt Gradients<br />

96% of Original Retention<br />

731-012<br />

0 5 10 MIN<br />

5<br />

4. AMP<br />

5. GMP


Tips on how to switch from chromatographic mode to chromatographic mode<br />

When changing from one mode of chromatography to another, i.e. from buffered ion exchange conditions to<br />

normal phase/HILIC conditions, performance difficulties can occur. This manifests itself in an apparent loss of<br />

column efficiency <strong>and</strong> a loss in integrity of the chromatogram. In order to avoid this difficulty it is strongly<br />

re<strong>com</strong>mended that the following wash procedure be employed when changing from ion exchange mode to<br />

normal phase mode (at least five column volumes of each).<br />

To change from a buffered solvent system to a normal phase solvent system:<br />

– flush the column with water – flush the column with 1M ammonium acetate<br />

– flush the column with water – flush the column with ethanol<br />

– run the column in normal phase solvents, i.e. hexane, ethyl acetate, etc.<br />

To change from normal phase solvent system to a buffered mobile phase:<br />

– flush the column with ethanol – flush the column with water<br />

– flush the column with buffered solvent of choice<br />

Hydrophilic Interaction Chromatography<br />

(HILIC) Mode using <strong>BioBasic</strong> <strong>AX</strong><br />

In the HILIC mode of chromatography,<br />

the stationary phase must be<br />

extremely polar. Polar analytes<br />

passing through the column in<br />

aqueous/organic mobile phase<br />

have a high affinity for this surface.<br />

The equilibrium that exists<br />

between the analyte in the<br />

stationary phase <strong>and</strong> the analyte in<br />

the mobile phase is controlled by<br />

the proportion of aqueous solvent<br />

present in the mobile phase. The<br />

higher the aqueous content of the<br />

mobile phase, the stronger the<br />

affinity the polar analyte has for it<br />

<strong>and</strong> the equilibrium moves<br />

towards that analyte in the mobile<br />

phase. The analyte then passes<br />

through the column more quickly,<br />

i.e retention time is reduced. This<br />

is the opposite of that seen for<br />

reversed phase chromatography<br />

where an increase in aqueous<br />

content results in an increase in<br />

retention. HILIC can also be used<br />

in gradient elution mode. Two<br />

figure 11a. Sugars in HILIC Mode figure 11b. Phospholipids in HILIC Mode<br />

1<br />

2<br />

3<br />

<strong>BioBasic</strong> ® <strong>AX</strong>, 5µm, 150x4.6mm<br />

Eluent: 75% ACN / 25% H 2 O<br />

Flow: 1.0 mL/min<br />

Detector: ELSD<br />

4<br />

5<br />

731-003<br />

0 2 4 6 MIN<br />

Sample:<br />

1. Glucose<br />

2. Maltose<br />

3. Maltotriose<br />

4. Maltotetraose<br />

5. Maltopentaose<br />

examples of <strong>BioBasic</strong> <strong>AX</strong> using<br />

this mode are given in Figures 11a<br />

<strong>and</strong> 11b. However, in Figure 11b<br />

there could be some mixed-mode<br />

interaction taking place. Some ion<br />

Sample:<br />

1. L-erythro-Sphingosine<br />

2. L-a-Phosphatidyl choline, egg<br />

3. Phosphatidyl ethanolamine, bovine<br />

4. lyso-Lecithin, egg<br />

2<br />

1<br />

731-013<br />

0 5 10 15 MIN<br />

<strong>BioBasic</strong><strong>AX</strong>, 5µm, 150x4.6mm<br />

Gradient: A: 95% ACN / 5% 5mM NH 4 Formate, pH 6.13<br />

B: 80% ACN / 20% 5mM NH 4 Formate, pH 6.13<br />

0%B 0-5 min., 0-100%B 5-15 min.<br />

Flow: 1.0 mL/min<br />

Detector: ELSD<br />

exchange interactions may occur<br />

because <strong>BioBasic</strong> <strong>AX</strong> is partially<br />

charged <strong>and</strong> phospholipids may<br />

have negative charge at this pH.<br />

3<br />

4<br />

9


10<br />

Technical Guide<br />

<strong>BioBasic</strong> ® <strong>SCX</strong> <strong>and</strong> <strong>AX</strong> <strong>Columns</strong><br />

Aromatic Acids Antibiotics Proteins<br />

Sample:<br />

1. Uracil<br />

2. Shikimic Acid<br />

3. Ascorbic Acid<br />

4. Phenylacetic Acid<br />

1<br />

2<br />

3<br />

Sample:<br />

1. Cyanocobalamin (B12)<br />

2. Riboflavin (B2)<br />

3. Pyridoxine (B6)<br />

4. Thiamine (B1)<br />

4<br />

2<br />

1<br />

3<br />

4<br />

5<br />

6<br />

7<br />

5. Sorbic Acid<br />

6. Benzoic Acid<br />

7. Vanillic Acid<br />

8. p-Coumeric Acid<br />

731-002<br />

732-007<br />

0 2 4 6 8 10 12 14 16 MIN<br />

<strong>BioBasic</strong> <strong>SCX</strong>, 5µm, 150x4.6mm<br />

Eluent: A: 50mM KH 2 PO 4 , pH 3.0<br />

B: 0.5M KH 2 PO 4 , pH 3.0<br />

Gradient: 10% B for 6 min, 100% B at 6.1 min<br />

Flow: 1.0 mL/min<br />

Detector: UV @ 254<br />

Temp: 50°<br />

*Note: Baseline subtracted<br />

1<br />

1<br />

2<br />

3<br />

Sample:<br />

1. Ac-G-G-G-L-G-G-A-G-G-L-K-amide<br />

2. Ac-K-Y-G-L-G-G-A-G-G-L-K-amide<br />

3. Ac-G-G-A-L-K-A-L-K-G-L-K-amide<br />

4. Ac-K-Y-A-L-K-A-L-K-G-L-K-amide<br />

3<br />

2<br />

731-004<br />

0 2 4 6 8 MIN 0 4 8 12 MIN 0 5 10 15 20 25 30 35 40 MIN<br />

<strong>BioBasic</strong> ® <strong>AX</strong>, 5µm, 50x4.6mm<br />

Eluent: A: 70mM NH 4 Acetate, pH 5.7<br />

B: Acetonitrile<br />

95%A / 5%B<br />

Flow: 1.0 mL/min<br />

Detector: UV @ 225<br />

8<br />

Sample:<br />

1. Cephaloridine<br />

2. Amoxicillin<br />

3. Ampicillin<br />

4. Cephalosporin C<br />

5. N-Acetylpenicillamine<br />

6. Penicillin G<br />

<strong>BioBasic</strong> <strong>AX</strong>, 5µm, 150x4.6mm<br />

Eluent: A: 10mM NH 4 Acetate, pH 6<br />

B: Acetonitrile<br />

90%A / 10%B<br />

Flow: 1.0 mL/min<br />

Detector: UV @ 220<br />

Temp: 35°C<br />

Vitamins Substituted Peptides<br />

4<br />

5<br />

6<br />

0 2 4 6 8 10 12 14 16 MIN<br />

<strong>BioBasic</strong> <strong>SCX</strong>, 5µm, 50x4.6mm<br />

Eluent: A: 10mM KH 2 PO 4 in 25% ACN (pH adjusted to 4.8 with H 3 PO 4 )<br />

B: A + 0.5M NaCl<br />

0->50% B in 20 min<br />

Flow: 1.0 mL/min<br />

Detector: UV @ 210<br />

4<br />

Sample:<br />

1. b-Lactoglobulin B<br />

2. b-Lactoglobulin A<br />

<strong>BioBasic</strong> <strong>AX</strong>, 5µm, 150x4.6mm<br />

Gradient: A: 0.02M TRIS, pH 6<br />

B: A + 1M NaAcetate, pH 6<br />

0-100%B in 40 min.<br />

Flow: 1.0 mL/min<br />

Detector: UV @ 280<br />

1<br />

2<br />

731-005<br />

732-005


<strong>BioBasic</strong> <strong>BioBasic</strong> <strong>BioBasic</strong> <strong>BioBasic</strong> <strong>BioBasic</strong>®®®®®<br />

<strong>SCX</strong> <strong>SCX</strong> <strong>SCX</strong> <strong>SCX</strong> <strong>SCX</strong> for for for for for 2D 2D 2D 2D 2D Proteomics<br />

Proteomics<br />

Proteomics<br />

Proteomics<br />

Proteomics<br />

Proteomics is the study of proteins<br />

<strong>and</strong> their interaction within organisms,<br />

including the human body. Diseased<br />

states can frequently be traced to<br />

problems with protein expression <strong>and</strong><br />

interaction. Proteomics accelerates<br />

drug discovery, since over 95 percent<br />

of all pharmaceuticals target proteins.<br />

Now that the genome has been<br />

sequenced, accelerated protein<br />

research is the next logical step,<br />

assisted by rapid improvements in the<br />

existing technologies.<br />

Much of the work in proteomics is<br />

conducted with electrophoresis <strong>and</strong> 2-<br />

D gels. However, the volume of work<br />

required calls for methods <strong>and</strong> tools<br />

that offer greater speed <strong>and</strong> sensitivity<br />

to produce rapid breakthroughs. The<br />

Thermo Finnigan ProteomX Workstation<br />

is one such tool, <strong>com</strong>bining HPLC<br />

<strong>and</strong> t<strong>and</strong>em MS with ion trap<br />

technology.<br />

2D proteomics <strong>com</strong>bines reversed<br />

phase <strong>and</strong> ion exchange chromatography<br />

to increase the efficiency of<br />

protein identification methods (see<br />

Figure 12). Co-eluting <strong>com</strong>ponents<br />

can be separated into different<br />

fractions, in effect removing interferences<br />

from more abundant co-eluting<br />

species. A typical two-dimensional<br />

LC/MS method involves separating<br />

fractions of protein digests by cation<br />

exchange chromatography. These<br />

separated fractions are then analyzed<br />

by reversed phase chromatography<br />

with MS/MS detection.<br />

A <strong>BioBasic</strong> <strong>SCX</strong> capillary column is<br />

used for the initial ion exchange<br />

separation. The columns have been<br />

designed to elute analytes with<br />

relatively low ionic strength buffer<br />

(salt) gradients, particularly for analysis<br />

of small organic molecules, nucleotides,<br />

peptides <strong>and</strong> small proteins.<br />

In addition, the columns are LC/MS<br />

<strong>com</strong>patible because volatile buffers<br />

figure 12. 2-Dimensional Protein Fractionation using <strong>BioBasic</strong> <strong>SCX</strong> <strong>and</strong> <strong>BioBasic</strong>18 Capillary <strong>Columns</strong><br />

500mM<br />

NH 4 CO 2 H<br />

20mM NH 4 CO 2 H<br />

0mM NH 4 CO 2 H<br />

Full Sample<br />

can be employed at low ionic<br />

strength, often with volatile organic<br />

modifiers present. A <strong>BioBasic</strong> C18<br />

capillary column is used for the<br />

reversed phase separation, based on<br />

a 300Å silica to ensure accuracy in<br />

quantification.<br />

Samp Samp Sampllllle Samp Samp e e e e LL<br />

Loooooaaaaadin LL<br />

din din ding/Fr ding/Fr<br />

g/Fr g/Fraction g/Fraction<br />

action action action Elutin Elutin Elutinggggg Elutin Elutin<br />

The sample of protein digest is<br />

loaded onto the 100x0.32mm ID<br />

<strong>BioBasic</strong> <strong>SCX</strong> cation exchange<br />

column using a mobile phase of<br />

0.01% formic acid (0.1% for later<br />

fractions) at a flow rate of 2 µL/min<br />

(100:1 split flow) for a period of 20<br />

minutes. To elute the fractions onto<br />

the 100x0.18mm ID <strong>BioBasic</strong> 18<br />

reversed phase column, sequential<br />

20 µL injections of increasing<br />

concentrations of NH 4 CO 2 H (0 mM,<br />

20mM, 50mM, 100mM, 200mM, in<br />

0.1% formic acid) were used. Three<br />

of these fractions are shown in<br />

Figure 12.<br />

Sample: BSA Digest<br />

Fractionation from <strong>BioBasic</strong> <strong>SCX</strong><br />

Column Dimensions: 100x0.32mm ID<br />

Inj. volume: 3µL (1500 fmol total digest on column)<br />

Fractions eluted with 20µL Ammonium Formate<br />

(concentrations listed, in 0.1% Formic Acid) onto<br />

100x0.180mm ID <strong>BioBasic</strong> 18 capillary<br />

Reversed Phase Separation of BSA Digest<br />

Mobile Phase: A: 0.01% Formic Acid<br />

B: ACN + 0.1% Formic Acid<br />

Flow: 2 µL/min<br />

Gradient: Time %B<br />

0 0<br />

3 0<br />

65 60<br />

Ionization Method: ESI+<br />

Sheath Gas: 10 arb units<br />

Capillary Temp.: 130°C<br />

Spray Voltage: 2.5 kV<br />

Capillary Voltage: 12.00 kV<br />

Scan Range: 300-2000u<br />

11


Innovators in life <strong>and</strong> laboratory sciences, Thermo Electron Corporation provides<br />

advanced analytical technologies, scientific instrumentation, laboratory informatics<br />

solutions, <strong>and</strong> laboratory consumables to help scientists <strong>and</strong> clinicians to discover<br />

new drugs, improve manufacturing processes, <strong>and</strong> diagnose illness <strong>and</strong> disease.<br />

Unparalleled in our capabilities, we can help you every step of the way – from sample<br />

preparation <strong>and</strong> sample analysis through interpretation of results.<br />

For more information on our products <strong>and</strong> services,<br />

please visit our website at: www.thermo.<strong>com</strong>/hypersil-keystone<br />

Technical information contained in this publication is for<br />

reference purposes only <strong>and</strong> is subject to change without<br />

notice. Every effort has been made to supply <strong>com</strong>plete <strong>and</strong><br />

accurate information; however, Thermo Electron assumes no<br />

responsibility <strong>and</strong> will not be liable for any errors, omissions,<br />

damage, or loss that might result from any use of the<br />

information contained therein (even if this information is<br />

properly followed <strong>and</strong> problems still arise).<br />

Reference to specifications supersede all previous information<br />

<strong>and</strong> are subject to change without notice.<br />

www.thermo.<strong>com</strong>/hypersil-keystone<br />

©2003 Thermo Electron, Printed in USA 05/03.<br />

ADVANCE, BetaBasic, BetaMax, BETASIL, <strong>BioBasic</strong>, DASH,<br />

DELTABOND, Duet, Fluophase, Hyperbond, Hypercarb, KAPPA,<br />

HOT POCKET, HyperGEL, HyperREZ, HyperSEP, Hypersil,<br />

HyPURITY, HyPURITY AQUASTAR, Javelin, KEYSTONE, MultiSEP,<br />

PIONEER, PRISM, Retain, SLIPFREE, UNIGUARD, UNIPHASE, <strong>and</strong><br />

Verify are trademarks of Thermo Electron Corporation.<br />

AquaSil TM Siliconizing Fluid for treating glass surfaces is sold by<br />

Pierce Chemical Co., Rockford, IL.<br />

All other trademarks are the property of their respective owners.<br />

Thermo Electron Corporation<br />

has direct subsidiary offices in<br />

North America, Europe <strong>and</strong> Japan.<br />

To <strong>com</strong>plement these<br />

direct subsidiaries, we maintain<br />

a network of representative<br />

organizations throughout the<br />

world. Use this reference list or<br />

visit our web site to locate the<br />

representative nearest you.<br />

France<br />

Tel. (33) 1 60 92 48 00<br />

Germany<br />

Tel. (49) 6103 4080<br />

United Kingdom<br />

Tel. (44) 1928 581000<br />

United States<br />

Tel. (01) 800 437 2999

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!